Canton Hathaway, LLC Senseonics Holdings, Inc. Transaction History

Canton Hathaway, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 10, 2020	SELL	$0.83 - $1.3 $39,342 - $61,620	-47,400 Closed	0 $0
Q3 2019 Oct 11, 2019	SELL	$0.97 - $1.94 $50,828 - $101,656	-52,400 Reduced 52.51%	47,400 $47,000
Q2 2019 Jul 15, 2019	BUY	$1.81 - $2.45 $58,644 - $79,380	32,400 Added 48.07%	99,800 $204,000
Q1 2019 Apr 10, 2019	SELL	$2.3 - $3.27 $24,379 - $34,662	-10,600 Reduced 13.59%	67,400 $165,000
Q4 2018 Feb 07, 2019	BUY	$2.49 - $4.54 $78,435 - $143,010	31,500 Added 67.74%	78,000 $202,000
Q3 2018 Oct 12, 2018	BUY	$3.4 - $4.84 $158,100 - $225,060	46,500 New	46,500 $222,000

140

59.9M

393K

254K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $363M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Canton Hathaway, LLC, based on Form 13F filings with the SEC.

Stay updated on Canton Hathaway, LLC with notifications on news.